BioSpace News Archive

The Longest Running Cannabis Terpene Laboratory Offers New Formulation and Delivery Applications for Terpenes in Water-Based Products of Any Kind

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, today announced that it will share new clinical data on its CO2 laser-based FiberLase™ Technology for minimally invasive treatment of endometriosis at the upcoming Society of Endometriosis and Uterine Disorders (SEUD) Congress 2019 in Montreal, Canada, May 16-18.

A national research study from Bankers Healthcare Group, a leading provider of financial solutions for healthcare professionals, examines how dentists manage their business finances and investments.

Moberg Pharma AB’s (“Company”) Annual General Meeting took place on Wednesday, May 15th, 2019 in the Company´s premises in Bromma, Sweden.

BioNJ’s 9th Annual BioPartnering Conference, developed with J.P. Morgan and Johnson & Johnson Innovation, took place last Wednesday, May 8, at The Palace at Somerset Park.

California Rehabilitation Institute, a three-way partnership among UCLA Health, Cedars-Sinai and Select Medical, appointed Steven C. Cramer, M.D., Director of Rehabilitation Research.

MPM Holdings Inc. (“Momentive” or the “Company”) (OTCQB: MPMQ), a global silicones and advanced materials company, and SJL Partners LLC (“SJL”), KCC Corporation (KS:002380) (“KCC”) and Wonik QnC Corporation (KOSDAQ:074600) (“Wonik”) (collectively, the “Investor Group”), today announced that the Investor Group has successfully completed the previously announced acquisition of Momentive.

Gold Standard Diagnostics Corp., announced today that the United States Patent and Trademark Office has issued U.S. Patent No. 10,222,375 covering the company’s AIX1000 system

Varex Imaging Corporation (Nasdaq: VREX) today said that it is not changing its guidance for fiscal year 2019 based on the List 3 tariff increase to 25% announced by the United States on May 9, 2019 or retaliatory tariffs announced by China on May 13, 2019.

Fengate Asset Management announced that it has closed total capital commitments of $1.1 billion for Fengate Core Infrastructure Fund III and affiliated vehicles, exceeding both its $750 million target and initial $1 billion hard cap.